Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

368 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Construct validity and responsiveness of ASAS Health Index assessed in two longitudinal studies of tumour necrosis factor alpha inhibitor initiation and dose reduction in patients with axial spondyloarthritis.
Lorincz M, Østergaard M, Wetterslev M, Sørensen IJ, Madsen OR, Christiansen SN, Hetland ML, Bakkegaard M, Klarlund M, Duer A, Boesen M, Gosvig KK, Pedersen SJ. Lorincz M, et al. Among authors: hetland ml. RMD Open. 2024 Dec 20;10(4):e004948. doi: 10.1136/rmdopen-2024-004948. RMD Open. 2024. PMID: 39794273 Free PMC article.
Impaired coagulation parameters in early RA are restored by effective antirheumatic therapy: a prospective pilot study.
Dijkshoorn B, Hansildaar R, Vedder D, Soutari N, Rudin A, Nordström D, Gudbjornsson B, Lend K, Uhlig T, Haavardsholm EA, Grondal G, Hetland ML, Heiberg MS, Østergaard M, Hørslev-Petersen K, Lampa J, van Vollenhoven RF, Antovic A, Nurmohamed MT. Dijkshoorn B, et al. Among authors: hetland ml. RMD Open. 2024 Dec 31;10(4):e004838. doi: 10.1136/rmdopen-2024-004838. RMD Open. 2024. PMID: 39740931 Free PMC article. Clinical Trial.
Systematic literature review and meta-analysis informing the EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer.
Sebbag E, Molina-Collada J, Ndoye R, Aletaha D, Askling J, Gente K, Bertheussen H, Bitoun S, Bolek EC, Buch MH, Burmester GR, Canhão HM, Chatzidionysiou K, Curtis JR, Danlos FX, Guimarães V, Hetland ML, Iannone F, Kostine M, Kragstrup TW, Kvien TK, Regierer AC, Schulze-Koops H, Sedmak N, Silva-Fernández L, Szekanecz Z, Lauper K, Finckh A, Gottenberg JE. Sebbag E, et al. Among authors: hetland ml. Ann Rheum Dis. 2024 Dec 20:ard-2024-225981. doi: 10.1136/ard-2024-225981. Online ahead of print. Ann Rheum Dis. 2024. PMID: 39739386
2024 EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer.
Sebbag E, Lauper K, Molina-Collada J, Aletaha D, Askling J, Gente K, Bertheussen H, Bitoun S, Bolek EC, Burmester GR, Canhão HM, Chatzidionysiou K, Curtis JR, Danlos FX, Guimarães V, Hetland ML, Iannone F, Kostine M, Kragstrup TW, Kvien TK, Regierer AC, Schulze-Koops H, Silva-Fernández L, Szekanecz Z, Buch MH, Finckh A, Gottenberg JE. Sebbag E, et al. Among authors: hetland ml. Ann Rheum Dis. 2024 Dec 20:ard-2024-225982. doi: 10.1136/ard-2024-225982. Online ahead of print. Ann Rheum Dis. 2024. PMID: 39739385
Legal obstacles jeopardise research in personalised medicine - experiences from a Nordic collaboration within rheumatology.
Glintborg B, Hansson M, Hammer HB, Klareskog L, Saevarsdottir S, Westerlind H, Rönnelid J, Gehring I, Benson M, Esbensen BA, Hetland ML, Padyukov L, Kragstrup TW, Hauge EM, AxnÄs BB, Krogh NS, Johannesson M, Askling J. Glintborg B, et al. Among authors: hetland ml. Scand J Public Health. 2024 Dec;52(8):1019-1025. doi: 10.1177/14034948231212711. Scand J Public Health. 2024. PMID: 39651649
Recording of non-musculoskeletal manifestations, comorbidities and safety outcomes in European spondyloarthritis registries: a survey.
Ahmadzay ZF, Heberg J, Jørgensen JB, Ørnbjerg LM, Østergaard M, Møller-Bisgaard S, Michelsen B, Loft AG, Jones GT, Hellamand P, Scherer A, Nissen MJ, Pavelka K, Závada J, Laas K, Vorobjov S, Nordström D, Sokka-Isler T, Regierer AC, Reich A, Gudbjornsson B, Thorarinsdottir K, Iannone F, Favalli EG, van de Sande M, Provan SA, Kvien TK, Rodrigues AM, Gonçalves CF, Codreanu C, Mogosan C, Rotar Z, Prikmajer KP, Castrejon I, Otero-Varela L, Di Giuseppe D, Wallman JK, Ciurea A, Möller B, Kenar-Artın G, Yıldırım TD, Macfarlane GJ, Rotariu O, Glintborg B, Hetland ML. Ahmadzay ZF, et al. Among authors: hetland ml. Rheumatol Adv Pract. 2024 Nov 5;8(4):rkae135. doi: 10.1093/rap/rkae135. eCollection 2024. Rheumatol Adv Pract. 2024. PMID: 39611201 Free PMC article.
Four-year secukinumab treatment outcomes in European real-world patients with axial spondyloarthritis and psoriatic arthritis.
Pons M, Georgiadis S, Østergaard M, Ahmadzay ZF, Glintborg B, Heberg J, Christensen SN, Rasmussen S, Loft AG, Castrejón I, Sánchez-Alonso F, Iannone F, Nordström D, Hokkanen AM, Ciurea A, Nissen MJ, Závada J, Pavelka K, Rotar Z, Pirkmajer KP, Michelsen B, Mielnik P, Bernardes M, Khmelinskii N, Laas K, Vorobjov S, Codreanu C, Macfarlane GJ, Jones GT, Gudbjornsson B, Palsson O, Wallman JK, van der Horst-Bruinsma I, Onen F, Hetland ML, Ørnbjerg LM. Pons M, et al. Among authors: hetland ml. Joint Bone Spine. 2024 Nov 26;92(3):105824. doi: 10.1016/j.jbspin.2024.105824. Online ahead of print. Joint Bone Spine. 2024. PMID: 39608666 Free article.
Circulating Adipokines and Response to Treatment in Patients With Early Rheumatoid Arthritis.
Vasileiadis GK, Zhang Y, Fatima T, van Vollenhoven R, Lampa J, Gudbjornsson B, Haavardsholm EA, Nordström D, Grondal G, Hørslev-Petersen K, Lend K, Heiberg MS, Hetland ML, Nurmohamed M, Uhlig T, Sokka-Isler T, Rudin A, Maglio C. Vasileiadis GK, et al. Among authors: hetland ml. ACR Open Rheumatol. 2025 Jan;7(1):e11756. doi: 10.1002/acr2.11756. Epub 2024 Nov 4. ACR Open Rheumatol. 2025. PMID: 39496558 Free PMC article.
368 results